**Background**
The Pregnane X receptor (PXR) is a member of the nuclear receptor superfamily and serves as a critical sensor for various xenobiotics, including drugs and environmental toxins. Upon activation, PXR regulates the transcription of numerous genes involved in drug metabolism and transport, most notably the cytochrome P450 (CYP) family. The induction of these enzymes by PXR ligands can significantly alter the pharmacokinetics of co-administered drugs, potentially leading to drug-drug interactions or therapeutic failure. Understanding the structure-activity relationships (SAR) of PXR ligands is essential for the development of safer pharmaceuticals and for probing the mechanisms of xenobiotic metabolism. In this context, we will introduce a PXR ligand – 4-Chloro-2-(trifluoroacetyl)aniline.
**Definition**
4-Chloro-2-(trifluoroacetyl)aniline is a small molecule ligand of the Pregnane X receptor (PXR) and serves as an analog of the antiretroviral drug Efavirenz.
**Biological Activity**
According to the 4-Chloro-2-(trifluoroacetyl)aniline description, this compound (Compound 10) was developed to investigate the divergence in activation between different Efavirenz analogs. In terms of 4-Chloro-2-(trifluoroacetyl)aniline biological activity, research indicates that while it acts as a ligand for PXR, it does not possess PXR activation activity. Specifically, it fails to induce the expression of Cyp3a11 mRNA, contrasting with the activating effects seen in other related analogs. This distinction provides critical insights into the specific chemical moieties required for the transcriptional activation of PXR. For researchers requiring detailed 4-Chloro-2-(trifluoroacetyl)aniline technical information, these findings highlight the compound’s utility as a tool for mapping the PXR ligand-binding domain and understanding the transition from binding to activation. In conclusion, 4-Chloro-2-(trifluoroacetyl)aniline is a PXR ligand that lacks the ability to induce Cyp3a11 mRNA expression.
Keywords
4-Chloro-2-(trifluoroacetyl)aniline, 154598-53-5, Drug Derivative, Pregnane X Receptor (PXR), Drug derivative, Pregnane X Receptor, Efavirenz, Pregnane X receptor, PXR, Cyp3a11, Inhibitor, inhibitor, inhibit
References